GO:0008484 sulfuric ester hydrolase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008484 (sulfuric ester hydrolase activity, synonym sulfatase activity) catalyzes hydrolysis of the sulfuric ester bond: RSO-R' + H2O = RSOOH + R'H.
• Most eukaryotic sulfatases require post-translational conversion of a catalytic cysteine to formylglycine (FGly) by the formylglycine-generating enzyme (FGE), a monooxygenase-type reaction.
• Lysosomal sulfatases form a growing family of enzymes whose deficiency causes multiple human storage disorders.
• Human sulfatases share a conserved alpha/beta fold and a metal-dependent catalytic mechanism, as revealed by crystallographic studies.
• Steroid sulfatase (STS) regulates estrogen and androgen bioavailability and is a validated target in hormone-dependent breast cancer.
• Sulfatases are also widespread in bacteria, where they contribute to mucin O-glycan degradation and carbohydrate processing.
Description
Sulfuric ester hydrolase activity (GO:0008484), commonly called sulfatase activity, is a molecular function that catalyzes the hydrolysis of sulfuric ester bonds according to the reaction RSO-R' + H2O = RSOOH + R'H. This activity is essential for the turnover of sulfated metabolites, including glycosaminoglycans, sulfolipids, and steroid sulfates, and it participates in diverse physiological processes ranging from lysosomal degradation to hormone regulation. Because sulfated molecules are abundant in the extracellular matrix and on cell surfaces, sulfatases are central to normal development and tissue homeostasis. In eukaryotes, most sulfatases belong to a conserved family that requires a unique post-translational modification: a catalytic cysteine residue is oxidized to formylglycine (FGly) by the formylglycine-generating enzyme (FGE). This modification is essential for catalytic activity, and its disruption leads to severe human diseases such as multiple sulfatase deficiency. Structural studies have shown that sulfatases adopt an alpha/beta fold with a metal ion in the active site that activates the formylglycine hydrate for nucleophilic attack on the sulfate ester. Research on sulfuric ester hydrolase activity spans cancer biology, neurobiology, and microbiology. Steroid sulfatase, for example, is a key enzyme in estrogen biosynthesis and a target for breast cancer therapy. Bacterial sulfatases contribute to the degradation of mucin O-glycans in the gut, influencing host-microbe interactions. Thus, understanding GO:0008484 is important for both fundamental enzymology and translational medicine.
sulfuric ester hydrolase activity At A Glance
| GO ID | GO:0008484 |
|---|---|
| GO term | sulfuric ester hydrolase activity |
| Ontology | molecular_function |
| Synonym | sulfatase activity; sulphuric ester hydrolase activity |
| Definition | Catalysis of the reaction: RSO-R' + H2O = RSOOH + R'H, the hydrolysis of a sulfuric ester bond. |
| Major function | Hydrolysis of sulfate esters in glycosaminoglycans, steroids, lipids, and other metabolites. |
| Cofactors | Most eukaryotic sulfatases require a formylglycine (FGly) residue generated by FGE; some require metal ions such as Ca2+ or Mg2+. |
| Subcellular locations | Lysosomes, endoplasmic reticulum, Golgi, and cell surface, depending on the specific enzyme. |
| Representative genes | ARSA, ARSB, GNS, IDS, SGSH, STS, SUMF1, and bacterial sulfatases. |
What Is GO:0008484?
GO:0008484, sulfuric ester hydrolase activity, is defined as the catalysis of the reaction RSO-R' + H2O = RSOOH + R'H. In this reaction, a sulfuric ester bond (an ester formed from sulfuric acid, O=SO(OH)2) is cleaved by water, releasing a sulfate group and an alcohol or related product. The term is synonymous with sulfatase activity and sulphuric ester hydrolase activity. This activity is classified under molecular_function and is distinct from other hydrolases because it specifically targets sulfate esters rather than phosphate or carboxyl esters.
Why Is sulfuric ester hydrolase activity Important in Cell Biology?
Sulfuric ester hydrolase activity is essential for normal cellular function because it controls the degradation and turnover of sulfated macromolecules. Deficiencies in specific sulfatases cause lysosomal storage disorders such as metachromatic leukodystrophy, mucopolysaccharidoses, and multiple sulfatase deficiency, which are severe and often progressive. In cancer, steroid sulfatase regulates the local production of estrogens and androgens, influencing the growth of hormone-dependent tumors. In the gut microbiome, bacterial sulfatases help degrade mucin O-glycans, affecting host-microbe interactions and intestinal health. Therefore, this activity is a focal point for drug development, enzyme replacement therapy, and microbiome research.
• Defects in sulfatases cause lysosomal storage disorders including metachromatic leukodystrophy and mucopolysaccharidoses.
• Multiple sulfatase deficiency results from mutations in SUMF1, the FGE gene, leading to loss of all sulfatase activities.
• Steroid sulfatase (STS) is a therapeutic target in hormone-dependent breast cancer and endometriosis.
• Sulfatases are involved in the degradation of glycosaminoglycans, which is critical for connective tissue homeostasis.
• Bacterial sulfatases contribute to mucin degradation and gut colonization by Akkermansia muciniphila.
• Sulfatase activity is important for the metabolism of sulfolipids and sulfated steroids in the brain and other tissues.
• Enzyme replacement therapy with recombinant sulfatases is used to treat several lysosomal storage diseases.
• Sulfatase inhibitors are being explored for cancer therapy and for modulating hormone levels.
• The unique formylglycine modification makes sulfatases attractive targets for protein engineering and bioconjugation.
• Sulfatases from marine bacteria are used in the enzymatic preparation of carrageenan and other polysaccharides.
What Happens During sulfuric ester hydrolase activity?
Substrate recognition and binding
In simple terms: The enzyme finds and grabs a molecule that has a sulfate group attached.
Sulfatases recognize specific sulfated substrates, such as glycosaminoglycans, steroid sulfates, or sulfolipids, through a substrate-binding pocket that accommodates the sulfate ester and the hydrophobic or charged portions of the substrate. Structural studies of human sulfatases have revealed that the active site is located at the bottom of a shallow cleft and contains a metal ion that helps position the sulfate group for catalysis. The substrate specificity varies among family members; for example, arylsulfatase A (ARSA) prefers sulfatides, while steroid sulfatase (STS) acts on steroid sulfates.
Formylglycine-dependent catalysis
In simple terms: A special modified amino acid in the enzyme's active site performs the chemical attack that breaks the sulfate bond.
Most eukaryotic sulfatases require a post-translationally generated formylglycine (FGly) residue at the active site. This residue is produced by the formylglycine-generating enzyme (FGE), which oxidizes a conserved cysteine to FGly in a monooxygenase-type reaction. The FGly residue is hydrated to a gem-diol, which acts as a nucleophile to attack the sulfur atom of the sulfate ester, leading to cleavage of the S-O bond and release of the product. This unique mechanism distinguishes sulfatases from other hydrolases and explains their dependence on FGE for activity.
Metal ion and cofactor requirements
In simple terms: Some sulfatases need a metal helper to work properly.
Many sulfatases contain a metal ion in their active site, typically calcium or magnesium, which is coordinated by conserved residues and helps stabilize the transition state during catalysis. The metal ion is not directly involved in the covalent chemistry but contributes to substrate binding and activation of the sulfate group. In addition, the FGly modification itself is essential; without it, the enzyme is inactive. Some bacterial sulfatases may use different metal cofactors or have distinct requirements.
Product release and enzyme turnover
In simple terms: After the sulfate is removed, the enzyme lets go of the products and is ready to work again.
Following hydrolysis, the sulfate group and the desulfated product are released from the active site, allowing the enzyme to undergo multiple rounds of catalysis. The release step may be rate-limiting for some sulfatases and can be influenced by substrate concentration and product inhibition. In lysosomes, the acidic pH optimizes the activity of many sulfatases and facilitates product clearance. Defects in product release or enzyme stability can lead to substrate accumulation and disease.
Key Genes Involved in GO:0008484 sulfuric ester hydrolase activity
The following genes encode enzymes with sulfuric ester hydrolase activity or proteins required for their function, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ARSA | Arylsulfatase A; hydrolyzes sulfatides in lysosomes | Deficiency causes metachromatic leukodystrophy; model for demyelination |
| ARSB | Arylsulfatase B; degrades dermatan sulfate and chondroitin sulfate | Deficiency causes Maroteaux-Lamy syndrome (MPS VI) |
| GNS | Glucosamine-6-sulfatase; removes sulfate from heparan sulfate | Deficiency causes Sanfilippo syndrome type D (MPS IIID) |
| IDS | Iduronate-2-sulfatase; degrades heparan sulfate and dermatan sulfate | Deficiency causes Hunter syndrome (MPS II) |
| SGSH | N-sulfoglucosamine sulfohydrolase; removes sulfate from heparan sulfate | Deficiency causes Sanfilippo syndrome type A (MPS IIIA) |
| STS | Steroid sulfatase; hydrolyzes steroid sulfates such as DHEA-S and estrone sulfate | Target in hormone-dependent breast cancer; deficiency causes X-linked ichthyosis |
| SUMF1 | Formylglycine-generating enzyme (FGE); activates sulfatases by modifying cysteine to FGly | Mutations cause multiple sulfatase deficiency |
| SUMF2 | Formylglycine-generating enzyme 2; may assist in sulfatase activation | Modifier of sulfatase activity; under investigation |
| GALNS | Galactosamine-6-sulfatase; degrades keratan sulfate | Deficiency causes Morquio syndrome A (MPS IVA) |
| ARSG | Arylsulfatase G; hydrolyzes sulfatides and other substrates | Associated with neuronal ceroid lipofuscinosis-like phenotypes |
| ARSD | Arylsulfatase D; function less characterized | Potential role in development; under study |
| ARSE | Arylsulfatase E; involved in bone development | Deficiency causes chondrodysplasia punctata |
| ARSH | Arylsulfatase H; testis-specific expression | Possible role in spermatogenesis; limited data |
| ARSL | Arylsulfatase L; involved in bone and cartilage development | Deficiency causes chondrodysplasia punctata |
| PAPSS2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2; provides sulfate donor for sulfation | Indirectly affects sulfatase substrates; mutations cause skeletal dysplasia |
| Bacterial sulfatases (e.g., from Akkermansia muciniphila) | Degrade sulfated mucin O-glycans | Gut microbiome research; mucin degradation |
| Carrageenan sulfatases (e.g., from marine bacteria) | Remove sulfate from carrageenan polysaccharides | Biotechnological production of furcellaran-like polysaccharides |
How Is sulfuric ester hydrolase activity Regulated?
Sulfuric ester hydrolase activity is regulated at multiple levels. First, the expression of sulfatase genes is controlled by transcription factors and epigenetic mechanisms; for example, steroid sulfatase (STS) expression in breast cancer is regulated by hormones and growth factors. Second, the activity of most eukaryotic sulfatases depends on the formylglycine-generating enzyme (FGE), encoded by SUMF1, which is itself regulated by cellular stress and developmental signals. Third, sulfatase activity can be modulated by post-translational modifications, such as glycosylation and proteolytic processing, and by the availability of cofactors and metal ions. Finally, the pH of the subcellular compartment (e.g., lysosomes) influences sulfatase activity, with most lysosomal sulfatases having acidic pH optima. These regulatory layers ensure that sulfatase activity is matched to cellular needs and can be disrupted in disease.
sulfuric ester hydrolase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ARSA | Metachromatic leukodystrophy; demyelination | Arsa knockout mouse; patient iPSC-derived neurons |
| SUMF1 | Multiple sulfatase deficiency | Sumf1 knockout mouse; patient fibroblasts |
| STS | Breast cancer; X-linked ichthyosis | STS knockout breast cancer cell lines; xenograft models |
| IDS | Hunter syndrome (MPS II) | Ids knockout mouse; enzyme replacement therapy models |
| GNS | Sanfilippo syndrome type D (MPS IIID) | Gns knockout mouse; patient fibroblasts |
Lysosomal storage disorders
Deficiencies in specific sulfatases cause lysosomal storage disorders characterized by the accumulation of sulfated substrates. For example, mutations in ARSA cause metachromatic leukodystrophy, a progressive demyelinating disease. Deficiencies in ARSB, GNS, IDS, SGSH, and GALNS lead to various mucopolysaccharidoses, each with distinct clinical features. Multiple sulfatase deficiency, caused by mutations in SUMF1, results in the loss of activity of all sulfatases and combines features of several storage disorders. These diseases highlight the critical role of sulfuric ester hydrolase activity in normal catabolism.
Cancer and hormone-dependent tumors
Steroid sulfatase (STS) hydrolyzes sulfated steroids such as estrone sulfate and DHEA sulfate, generating free estrogens and androgens that can promote tumor growth. In breast cancer, STS activity in tumor cells contributes to local estrogen production, and STS inhibitors are being developed as endocrine therapy. Progestins can also regulate STS activity in breast cancer cells, further linking sulfatase activity to hormone signaling. Thus, STS is a validated target in hormone-dependent cancers.
Neurodegeneration and brain function
Sulfatases are important for brain lipid metabolism. Arylsulfatase A (ARSA) degrades sulfatides, and its deficiency causes metachromatic leukodystrophy, a severe neurodegenerative disease. Other sulfatases, such as ARSG, have been linked to neuronal ceroid lipofuscinosis-like phenotypes in animal models. The brain is rich in sulfatides and other sulfolipids, and their turnover by sulfatases is essential for myelin maintenance and neuronal function.
Microbiome and gut health
Bacterial sulfatases contribute to the degradation of mucin O-glycans, which are heavily sulfated. Akkermansia muciniphila uses sulfatases to break down mucin and colonize the gut mucosa. This activity influences host-microbe interactions and may affect intestinal barrier function and inflammation. Therefore, sulfuric ester hydrolase activity is also relevant to microbiome research and gut health.
From sulfuric ester hydrolase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a specific sulfatase cause substrate accumulation? | CRISPR knockout of the sulfatase gene in cell lines (e.g., ARSA, IDS) |
| Does a point mutation in the catalytic site abolish enzyme activity? | CRISPR point mutation (e.g., cysteine to alanine in the FGly motif) |
| Can a disease-associated mutation be corrected? | CRISPR knock-in of wild-type sequence or base editing |
| Where is the sulfatase localized in the cell? | Knock-in of a fluorescent tag (e.g., GFP) at the endogenous locus |
| Does overexpression of a sulfatase alter substrate levels? | CRISPR overexpression (e.g., CRISPRa) or lentiviral overexpression |
| What is the role of FGE in activating multiple sulfatases? | SUMF1 knockout or point mutation models |
How to Study the sulfuric ester hydrolase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic activity assay | Sulfatase catalytic activity using chromogenic/fluorogenic substrates | Diagnosis of sulfatase deficiencies; inhibitor screening |
| X-ray crystallography | Three-dimensional structure of sulfatases | Mechanistic studies; drug design |
| CRISPR knockout screen | Genes required for sulfatase activity or substrate metabolism | Identification of novel regulators |
| Mass spectrometry | Levels of sulfated and desulfated metabolites | Glycomics/lipidomics in disease models |
| Western blot | Protein expression and formylglycine modification | Validation of FGE-dependent activation |
| Immunofluorescence | Subcellular localization of sulfatases | Lysosomal trafficking studies |
| Enzyme replacement therapy monitoring | Sulfatase activity in patient samples | Assessment of treatment efficacy |
| CRISPRa/CRISPRi | Titration of sulfatase expression | Dose-response studies |
Enzymatic activity assays
Sulfatase activity can be measured using chromogenic or fluorogenic substrates such as p-nitrocatechol sulfate or 4-methylumbelliferyl sulfate. These assays quantify the release of sulfate or the formation of a colored/fluorescent product and are widely used to diagnose sulfatase deficiencies. Activity assays can be performed on cell lysates, tissue homogenates, or purified enzymes, and are often combined with inhibitors to determine specificity.
Structural biology and crystallography
X-ray crystallography and cryo-electron microscopy have provided detailed insights into the three-dimensional structures of sulfatases, revealing the alpha/beta fold, the active-site metal ion, and the formylglycine residue. These methods are essential for understanding substrate binding and catalytic mechanism, and for structure-guided drug design.
Genetic and CRISPR screens
CRISPR knockout screens can identify genes required for sulfatase activity or for the metabolism of sulfated substrates. For example, a genome-wide screen for regulators of steroid sulfatase activity could reveal novel modulators. Similarly, CRISPR interference (CRISPRi) or activation (CRISPRa) can be used to titrate sulfatase expression and study dose-dependent effects.
Mass spectrometry and glycomics
Mass spectrometry-based glycomics and lipidomics can quantify sulfated substrates and their desulfated products, providing a direct readout of sulfatase activity in biological samples. These methods are particularly useful for studying the degradation of glycosaminoglycans and sulfatides in lysosomal storage disorders.
How CRISPR Can Be Used to Study GO:0008484 sulfuric ester hydrolase activity
Knockout
CRISPR knockout of a sulfatase gene (e.g., ARSA, IDS, STS) can create isogenic cell models to study substrate accumulation, enzyme function, and disease mechanisms. Knockout cells can be used to test the efficacy of enzyme replacement or gene therapy approaches. For example, ARSA knockout cells accumulate sulfatides and can be used to screen for therapeutic compounds.
Point Mutation
CRISPR point mutation can introduce disease-associated missense mutations or alter the catalytic cysteine residue required for formylglycine formation. Such models help dissect the impact of specific mutations on enzyme activity, stability, and substrate specificity. For example, mutating the catalytic cysteine in a sulfatase abolishes activity and mimics multiple sulfatase deficiency.
Knock-in
CRISPR knock-in can be used to insert a fluorescent tag (e.g., GFP) or a epitope tag at the endogenous sulfatase locus to study protein localization and trafficking in real time. Knock-in of wild-type or mutant sequences can also correct or introduce disease-causing mutations for functional studies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase sulfatase levels to study gain-of-function effects, such as enhanced degradation of sulfated substrates or altered hormone signaling. Overexpression models are useful for drug screening and for producing recombinant sulfatases for enzyme replacement therapy.
How EDITGENE Supports sulfuric ester hydrolase activity Research
Researchers studying sulfuric ester hydrolase activity-related genes often need to determine whether a candidate gene is causally involved in substrate turnover, disease pathogenesis, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for sulfuric ester hydrolase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| GNS Knockout HEK293 Cell Line | EDJ-KQ2252 | Human | 2799 | Details Get a Quote |
| GALNS Knockout HEK293 Cell Line | EDJ-KQ3354 | Human | 2588 | Details Get a Quote |
| ARSA Knockout HEK293 Cell Line | EDJ-KQ4095 | Human | 410 | Details Get a Quote |
| STS Knockout HEK293 Cell Line | EDJ-KQ4101 | Human | 412 | Details Get a Quote |
| IDS Knockout HEK293 Cell Line | EDJ-KQ4973 | Human | 3423 | Details Get a Quote |
| SGSH Knockout HEK293 Cell Line | EDJ-KQ5746 | Human | 6448 | Details Get a Quote |
| SULF1 Knockout HEK293 Cell Line | EDJ-KQ7896 | Human | 23213 | Details Get a Quote |
| ARSI Knockout HEK293 Cell Line | EDJ-KQ12444 | Human | 340075 | Details Get a Quote |
| ARSJ Knockout HEK293 Cell Line | EDJ-KQ12445 | Human | 79642 | Details Get a Quote |
| SULF2 Knockout HEK293 Cell Line | EDJ-KQ15560 | Human | 55959 | Details Get a Quote |
| ARSB Knockout HEK293 Cell Line | EDJ-KQ17901 | Human | 411 | Details Get a Quote |
| GNS Knockout A-549 Cell Line | EDJ-KQ23935 | Human | 2799 | Details Get a Quote |
| GNS Knockout HCT 116 Cell Line | EDJ-KQ23936 | Human | 2799 | Details Get a Quote |
| GNS Knockout HeLa Cell Line | EDJ-KQ23937 | Human | 2799 | Details Get a Quote |
| ARSB Knockout A-549 Cell Line | EDJ-KQ24149 | Human | 411 | Details Get a Quote |
Displaying Records 1 To 15 Of 44 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About sulfuric ester hydrolase activity
What is sulfuric ester hydrolase activity?
Sulfuric ester hydrolase activity (GO:0008484) is the catalysis of the hydrolysis of a sulfuric ester bond, releasing a sulfate group and an alcohol. It is also known as sulfatase activity.
What genes are involved in sulfuric ester hydrolase activity?
Genes include ARSA, ARSB, GNS, IDS, SGSH, STS, SUMF1, and many others encoding sulfatases or their activating enzyme FGE.
What diseases are associated with sulfatase deficiencies?
Deficiencies cause lysosomal storage disorders such as metachromatic leukodystrophy, mucopolysaccharidoses, and multiple sulfatase deficiency.
How is sulfuric ester hydrolase activity measured?
It is measured using chromogenic or fluorogenic substrates like p-nitrocatechol sulfate or 4-methylumbelliferyl sulfate in activity assays.
What is the role of formylglycine in sulfatases?
Formylglycine is a post-translational modification of a catalytic cysteine, essential for sulfatase activity, and is generated by the formylglycine-generating enzyme (FGE).
Is steroid sulfatase a drug target?
Yes, steroid sulfatase (STS) is a target in hormone-dependent breast cancer because it generates active estrogens from sulfated precursors.
Can CRISPR be used to study sulfatases?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study sulfatase function and disease mechanisms.
What is multiple sulfatase deficiency?
It is a rare disorder caused by mutations in SUMF1, leading to loss of activity of all sulfatases and combining features of several storage diseases.
Are bacterial sulfatases important?
Yes, bacterial sulfatases help degrade sulfated mucin O-glycans and are important for gut microbiome function.
What are the model systems for studying sulfatase activity?
Common models include knockout mice, patient-derived fibroblasts, iPSC-derived neurons, and CRISPR-engineered cell lines.
Conclusion
Sulfuric ester hydrolase activity (GO:0008484) is a fundamental enzymatic function required for the turnover of sulfated molecules in health and disease. Its unique formylglycine-dependent mechanism and its involvement in lysosomal storage disorders, cancer, and microbiome biology make it a compelling subject for both basic and translational research. CRISPR-based models offer powerful tools to dissect the roles of individual sulfatases and to develop new therapeutic strategies.
References
- 1. Lübke T et al.. 2020. Lysosomal sulfatases: a growing family.. Biochem J 477(20):3963-3983 PMID: 33120425
- 2. Iwamori M. 2005. Estrogen sulfatase.. Methods Enzymol 400:293-302 PMID: 16399356
- 3. Ghosh D. 2005. Three-dimensional structures of sulfatases.. Methods Enzymol 400:273-93 PMID: 16399355
- 4. Bakshani CR et al.. 2025. Carbohydrate-active enzymes from Akkermansia muciniphila break down mucin O-glycans to completion.. Nat Microbiol 10(2):585-598 PMID: 39891011
- 5. Pasqualini JR. 2007. Progestins and breast cancer.. Gynecol Endocrinol 23 Suppl 1:32-41 PMID: 17943537
- 6. Peng J et al.. 2015. Eukaryotic formylglycine-generating enzyme catalyses a monooxygenase type of reaction.. FEBS J 282(17):3262-74 PMID: 26077311
- 7. Préchoux A et al.. 2016. Enzyme-Assisted Preparation of Furcellaran-Like κ-/β-Carrageenan.. Mar Biotechnol (NY) 18(1):133-43 PMID: 26585588
- 8. Ghosh D. 2007. Human sulfatases: a structural perspective to catalysis.. Cell Mol Life Sci 64(15):2013-22 PMID: 17558559
